Owing to their characteristic structures,
metal–organic
frameworks (MOFs) are considered as the leading candidate for drug-delivery
materials. However, controlling the synthesis of MOFs with uniform
morphology and high drug-loading/release efficiencies is still challenging,
which greatly limits their applications and promotion. Herein, a multifunctional
MOF-based drug-delivery system (DDS) with a controlled pore size of
100–200 nm for both therapeutic and bioimaging purposes was
successfully synthesized in one step. Fe-MOF-based microcapsules were
synthesized through a competitive coordination method, which was profited
from the intrinsic coordination characteristics of the Fe element
and the host-guest supramolecular interactions between Fe3+ and polyoxometalates anions. This as-synthesized macroporous DDS
could greatly increase the drug-loading/release rate (77%; 83%) and
serve as a magnetic resonance (MR) contrast agent. Because an Fe-containing
macroporous DDS presents ultrahigh drug loading/release, the obtained
5-FU/Fe-MOF-based microcapsules displayed good biocompatibility, extremely
powerful inhibition of tumor growth, and satisfactory MR imaging capability.
Given all these advantages, this study integrates high therapeutic
effect and diagnostic capability via a simple and effective morphology-controlling
strategy, aiming at further facilitating the applications of MOFs
in multifunctional drug delivery.
Five Mn(i) photo-activated carbon monoxide-releasing molecules were synthesized by reactions of MnBr(CO)5 with L1–L4, and characterized via single crystal X-ray diffraction, 1H-NMR, 13C-NMR, IR, UV-vis and fluorescence spectroscopy.
Mesoporous TiO 2 with anatase crystalline structure (MTiO 2 /CAS) has been synthesized by using chrome azurol S (CAS, 2 00 ,6 00 -dichloro-3,3 0 -dimethyl-4 0 -hydroxy-3 00 -sulfofuchson-5,5 0 -dicarboxylic acid) as template. It was characterized by X-ray diffraction, nitrogen adsorption/desorption, diffuse reflectance UV-visible and FT-IR spectrometry, and transmission electron microscopy. It was found that MTiO 2 /CAS had substantial photocatalytic activity in the degradation of methylthionine chloride, rhodamine B, gentian violet, safranin T, methyl violet, and fuchsine basic whereas Degussa P25 (P25) had negligible photodegradation yield (\6%) under visible light irradiation.
Human umbilical cord mesenchymal stem cells (hUC-MSCs) are potential stromal cells which are regarded as the most feasible stem cell group in cell therapy. The maintenance of cell survival without differentiation is important in cell transplantation and stem cell therapy. However, negative factors exist in cell transplantation. Lysophosphatidic acid (LPA) is a non-antigenic small molecule phospholipid which induced several fundamental cellular responses, such as cell proliferation, apoptosis and migration. In this study we aimed to explore the effects of LPA on the survival and differentiation of MSCs and its availability in cell therapy. We found that LPA stimulated hUC-MSC proliferation and protected hUC-MSCs from lipopolysaccharide (LPS) induced apoptosis. We also observed that CD29, CD44, CD73, CD90 and CD105 were expressed, whereas CD34 and CD45 were not expressed in hUC-MSCs, and these makers have no change in LPA containing medium, which indicated that LPA accelerated the survival of hUC-MSCs in an undifferentiating status. We also demonstrated that higher expressed LPAR1 involved in LPA stimulated cell survival action. LPA stimulated cell proliferation was associated with LPAR1 mediated Gi/o-proteins/ERK1/2 pathway. On the other hand, LPA protected hUC-MSCs from LPS-induced apoptosis through suppressing caspase-3 activation by LPAR1 coupled with a G protein, but not Gi/o or Gq/11 in hUC-MSC. Collectively, this study demonstrated that LPA increased the proliferation and survival of hUC-MSCs without differentiation through LPAR1 mediated manner. Our findings provide that LPA as a anti-apoptotic agent having potential application prospect in cell transplantation and stem cell therapy.Electronic supplementary materialThe online version of this article (doi:10.1007/s10495-017-1399-6) contains supplementary material, which is available to authorized users.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.